Anteris Technologies Ltd (ASX: AVR)

Market Cap	204.63M
Revenue (ttm)	3.89M
Net Income (ttm)	-87.90M
Shares Out	21.14M
EPS (ttm)	-5.08
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,618
Open	9.26
Previous Close	9.22
Day's Range	9.10 - 9.82
52-Week Range	8.68 - 23.93
Beta	0.71
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 22, 2024

About Anteris Technologies

Anteris Technologies Ltd, a structural heart company, engages in the designing, developing, and commercializing medical devices. The company’s lead product candidate is DurAVR, a transcatheter heart valve (THV) for the treatment of aortic stenosis. It also offers ComASUR, a delivery system that provides controlled deployment and placement of the DurAVR THV with balloon-expandable delivery, which allow precise alignment of the heart’s native commissures to achieve ideal valve positioning; and ADAPT, a patented anti-calcification tissue technolog...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1999
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AVR

Financial Performance

In 2023, Anteris Technologies's revenue was 4.11 million, a decrease of -10.43% compared to the previous year's 4.59 million. Losses were -67.33 million, 51.9% more than in 2022.